TR200100885T2 - 2-Metil-tieno-benzodiazepin formülasyonu - Google Patents

2-Metil-tieno-benzodiazepin formülasyonu

Info

Publication number
TR200100885T2
TR200100885T2 TR2001/00885T TR200100885T TR200100885T2 TR 200100885 T2 TR200100885 T2 TR 200100885T2 TR 2001/00885 T TR2001/00885 T TR 2001/00885T TR 200100885 T TR200100885 T TR 200100885T TR 200100885 T2 TR200100885 T2 TR 200100885T2
Authority
TR
Turkey
Prior art keywords
thieno
methyl
benzodiazepine formulation
formulation
benzodiazepine
Prior art date
Application number
TR2001/00885T
Other languages
English (en)
Turkish (tr)
Inventor
Harry Ferguson Thomas
Arthur Bunnell Charles
Arnold Hendriksen Barry
Vicente Sanchez-Felix Manuel
Edward Tupper David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200100885T2 publication Critical patent/TR200100885T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR2001/00885T 1998-09-30 1999-03-24 2-Metil-tieno-benzodiazepin formülasyonu TR200100885T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
TR200100885T2 true TR200100885T2 (tr) 2001-08-21

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00885T TR200100885T2 (tr) 1998-09-30 1999-03-24 2-Metil-tieno-benzodiazepin formülasyonu

Country Status (28)

Country Link
EP (1) EP1119359B1 (enExample)
JP (1) JP4551988B2 (enExample)
CN (1) CN1146422C (enExample)
AT (2) ATE267602T1 (enExample)
AU (1) AU759751B2 (enExample)
BR (1) BR9914156A (enExample)
CA (1) CA2344873A1 (enExample)
CZ (1) CZ302367B6 (enExample)
DE (2) DE69935873T2 (enExample)
DK (2) DK1119359T3 (enExample)
EA (1) EA002580B1 (enExample)
ES (2) ES2285294T3 (enExample)
GE (1) GEP20094818B (enExample)
HK (1) HK1041199B (enExample)
HR (1) HRP20010238B1 (enExample)
HU (1) HU227400B1 (enExample)
ID (1) ID29574A (enExample)
IL (2) IL141766A0 (enExample)
MY (1) MY126476A (enExample)
NO (1) NO328243B1 (enExample)
NZ (1) NZ510208A (enExample)
PL (1) PL196821B1 (enExample)
PT (2) PT1119359E (enExample)
SK (1) SK285944B6 (enExample)
TR (1) TR200100885T2 (enExample)
TW (1) TW577890B (enExample)
UA (1) UA66872C2 (enExample)
WO (1) WO2000018408A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047933A1 (en) * 1999-12-28 2001-07-05 Cipla Limited New polymorphic forms of olanzapine
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
EA200701065A1 (ru) * 2004-11-16 2007-12-28 Элан Фарма Интернэшнл Лтд. Инъецируемые составы, содержащие нанодисперсный оланзапин
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
EP1838716B1 (en) * 2005-01-05 2011-06-01 Eli Lilly And Company Olanzapine pamoate dihydrate
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
RU2548753C2 (ru) * 2009-11-16 2015-04-20 Ипсен Фарма С.А.С. Фармацевтические композиции лигандов рецепторов меланокортинов
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
WO2012053654A1 (en) 2010-10-18 2012-04-26 Dainippon Sumitomo Pharma Co., Ltd. Sustained-release formulation for injection
US9604995B2 (en) 2013-02-13 2017-03-28 Neuland Laboratories Limited Process for the preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
JP2020511483A (ja) * 2017-03-20 2020-04-16 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH 徐放性オランザピン製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA933134B (en) * 1992-05-08 1993-11-30 Akzo Nv Depot preparation
KR100333115B1 (ko) * 1992-11-17 2002-12-02 미츠비시 파마 코포레이션 항정신병약함유서방성마이크로스피어및이의제조방법
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
TR199900639T2 (xx) * 1996-09-23 1999-06-21 Eli Lilly And Company Olanzapin dihidrat D.
US6169084B1 (en) * 1997-09-30 2001-01-02 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation

Also Published As

Publication number Publication date
ID29574A (id) 2001-09-06
DK1468689T3 (da) 2007-08-13
CN1320038A (zh) 2001-10-31
EA002580B1 (ru) 2002-06-27
PL196821B1 (pl) 2008-02-29
HUP0103636A3 (en) 2003-05-28
EP1119359A1 (en) 2001-08-01
HRP20010238A2 (en) 2002-04-30
PL346981A1 (en) 2002-03-11
IL141766A (en) 2006-12-31
NO20011583D0 (no) 2001-03-28
TW577890B (en) 2004-03-01
NO328243B1 (no) 2010-01-11
GEP20094818B (en) 2009-11-10
DE69935873T2 (de) 2008-01-10
HK1041199B (en) 2005-03-18
EP1119359A4 (en) 2001-12-19
JP2002525330A (ja) 2002-08-13
IL141766A0 (en) 2002-03-10
PT1119359E (pt) 2004-08-31
WO2000018408A1 (en) 2000-04-06
ATE267602T1 (de) 2004-06-15
HRP20010238B1 (en) 2006-05-31
CN1146422C (zh) 2004-04-21
AU3362799A (en) 2000-04-17
EA200100406A1 (ru) 2001-10-22
MY126476A (en) 2006-10-31
BR9914156A (pt) 2001-06-26
CZ302367B6 (cs) 2011-04-13
SK4162001A3 (en) 2002-03-05
CZ20011149A3 (cs) 2002-01-16
HU227400B1 (en) 2011-05-30
PT1468689E (pt) 2007-07-09
NO20011583L (no) 2001-03-28
CA2344873A1 (en) 2000-04-06
DK1119359T3 (da) 2004-08-16
DE69935873D1 (de) 2007-05-31
ES2285294T3 (es) 2007-11-16
AU759751B2 (en) 2003-05-01
HUP0103636A2 (hu) 2002-01-28
DE69917663D1 (de) 2004-07-01
DE69917663T2 (de) 2005-05-25
UA66872C2 (uk) 2004-06-15
JP4551988B2 (ja) 2010-09-29
ES2221376T3 (es) 2004-12-16
NZ510208A (en) 2003-04-29
HK1041199A1 (en) 2002-07-05
SK285944B6 (sk) 2007-11-02
EP1119359B1 (en) 2004-05-26
ATE359793T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
TR200100885T2 (tr) 2-Metil-tieno-benzodiazepin formülasyonu
BR9903578B1 (pt) composiÇÕes de toner.
ES2180899T3 (es) Dihidrato d de olanzapina.
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
DE69826127D1 (de) 2-substituierte 4,5-diarylimidazole
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
BR9902084A (pt) Heterociclos.
ATE251457T1 (de) Substituierte 1,2,3,4-tetrahydro-2- dibenzofuranamine und 2- aminocyclohepta(b)benzofurane
DK1073447T3 (da) N1-modificerede glycopeptider
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.
FI982378A0 (fi) Järjestely kohteen tutkimiseen
BR9908946B1 (pt) forração.
IT1311356B1 (it) Disposizione di macchine.
TR199900757A3 (tr) Fenoksifenilsülfonil halidlerin hazirlanmasi için islem.
ECSP972052A (es) Quinoxalinadionas
FI974583A0 (fi) Avvattningsfoerfarande och -element i samband med en sellulosatorkmaskin el.dyl.
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ITRM990762A0 (it) Procedimento per la preparazione di filati ondee o compensina.
ES1039318Y (es) Conjunto de sartenes.
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
IT1287307B1 (it) Pertica per il livellamento di superfici intonacate.
ECSP993288A (es) ACTIVADORES DE hPPARy y hPPARa
FI973824A0 (fi) Foerfarande och maetningsapparat i samband med en traebehandlingsanordning
ES1030098Y (es) Tapa-casquillo nivelador, para somieres de ballestas.